{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:40:10Z","timestamp":1648557610902},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/bf00685423","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T16:59:32Z","timestamp":1101661172000},"page":"S63-S65","source":"Crossref","is-referenced-by-count":3,"title":["Experience of the Belgian Society of Medical Oncology with single-administration 5 g\/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"R.","family":"Paridaens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Focan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Beauduin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Closon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tueni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vindevoghel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Majois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"T'Hooft-Andry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.1987.5.5.799","volume":"5","author":"GL Andriole","year":"1987","unstructured":"Andriole GL, Sandlung J, Miser J, Arasi V, Linehan M, Magrath I (1987) The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. J Clin Oncol 5: 799","journal-title":"J Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(85)90011-8","volume":"12","author":"WP Brade","year":"1985","unstructured":"Brade WP, Herdrich K, Varini M (1985) Ifosfamide?pharmacology, safety and therapeutic potential. Cancer Treat Rev 12: 1","journal-title":"Cancer Treat Rev"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0277-5379(87)90075-7","volume":"23","author":"V Bramwell","year":"1987","unstructured":"Bramwell V, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, Van Oosterom AT (EORTC Soft-tissue and Bone Sarcoma Group) (1987) Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft-tissue sarcomas. Eur J Cancer Clin Oncol 23: 311","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2964(77)90234-1","volume":"13","author":"JL Hayward","year":"1977","unstructured":"Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response in advanced breast cancer. Eur J Cancer 13: 89","journal-title":"Eur J Cancer"},{"key":"CR5","unstructured":"Loehrer PJ (ed) (1989) Current developments and future direction with ifosfamide. Semin Oncol 16 (1) [Suppl 3]"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0277-5379(86)90368-8","volume":"22","author":"C Meanwell","year":"1986","unstructured":"Meanwell C, Blake A, Kelly K, Honigsberger L, Blackledge G (1986) Prediction of ifosfamide\/mesna associated encephalopathy. Eur J Cancer Clin Oncol 22: 815","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF00398184","volume":"114","author":"G Steger","year":"1988","unstructured":"Steger G, Dittrich C, Schlappack O, Mader R, Herold C, Brade W, Keller A, Moser K (1988) Toxicity and response to high-dose ifosfamide\/mesna as salvage therapy of advanced breast cancer. J Cancer Res Clin Oncol 114: 602","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00685423\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:24Z","timestamp":1554459024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00685423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":7,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1990]]}},"alternative-id":["BF00685423"],"URL":"https:\/\/doi.org\/10.1007\/bf00685423","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990]]}}}